TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study
PanCareLIFE 研究表明，TCERG1L 等位基因变异与儿童癌症患者顺铂引起的听力损失相关。
期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-021-00178-z
Meijer, A J M; Diepstraten, F A; Langer, T; Broer, L; Domingo, I K; Clemens, E; Uitterlinden, A G; de Vries, A C H; van Grotel, M; Vermeij, W P; Ozinga, R A; Binder, H; Byrne, J; van Dulmen-den Broeder, E; Garrè, M L; Grabow, D; Kaatsch, P; Kaiser, M; Kenborg, L; Winther, J F; Rechnitzer, C; Hasle, H; Kepak, T; Kepakova, K; Tissing, W J E; van der Kooi, A L F; Kremer, L C M; Kruseova, J; Pluijm, S M F; Kuehni, C E; van der Pal, H J H; Parfitt, R; Spix, C; Tillmanns, A; Deuster, D; Matulat, P; Calaminus, G; Hoetink, A E; Elsner, S; Gebauer, J; Haupt, R; Lackner, H; Blattmann, C; Neggers, S J C M M; Rassekh, S R; Wright, G E B; Brooks, B; Nagtegaal, A P; Drögemöller, B I; Ross, C J D; Bhavsar, A P; Am Zehnhoff-Dinnesen, A G; Carleton, B C; Zolk, O; van den Heuvel-Eibrink, M M
